Akamis Bio logo

Akamis Bio

Harnessing the Power of Tumor Gene Therapy to Turn the Tide in the Battle Against Cancer

50 employees · est. 2010 · Abingdon, United Kingdom

VS
iTeos Therapeutics logo

iTeos Therapeutics

Cancer Immunotherapies by Design

186 employees · est. 2011 · Cambridge, United States

Akamis Bio is the older company (2010 vs 2011); iTeos Therapeutics is the larger of the two.

Side-by-Side Comparison

Akamis Bio iTeos Therapeutics
Founded
2010 older 2011
Headquarters
Abingdon, United Kingdom Cambridge, United States
Employees
50 186 larger
Industry
Biotechnology, Health Care, Health and Wellness Biotechnology, Health Care
Funding Stage
Convertible Note Post Ipo Equity
Total Funding
$102.70M $362.74M
Funding Rounds
9 9
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Not tracked yet Biopharmaceutical Company, Immuno-oncology, Clinical-stage, Tumor Immunology, Immunosuppressive Pathways, Product Candidates, Immune Response, Cancer Therapy, Pharmacologic Properties, TIGIT/CD226 Axis, Adenosine Pathway, Research Center, Watertown, Gosselies
Website
akamisbio.com iteostherapeutics.com
Akamis Bio logo

About Akamis Bio

Akamis Bio is a biotechnology company founded in 2010. Specializing in the Biotechnology and Health Care industries, it has received a significant $30.00M investment through a Convertible Note investment in 05 January 2023. This investment comes from reputable investors such as Arch Venture Partners...

iTeos Therapeutics logo

About iTeos Therapeutics

iTeos Therapeutics is a clinical-stage biopharmaceutical company founded in 2011 and headquartered in Watertown, MA with a research center in Gosselies, Belgium. The company's slogan, "Cancer Immunotherapies by Design," reflects its focus on pioneering the discovery and development of a new generati...

We will tell you when either one moves

BounceWatch watches Akamis Bio and iTeos Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Akamis Bio and iTeos Therapeutics — by email.

Frequently Asked Questions

Akamis Bio — Harnessing the Power of Tumor Gene Therapy to Turn the Tide in the Battle Against Cancer. iTeos Therapeutics — Cancer Immunotherapies by Design. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Akamis Bio has raised $102.70M while iTeos Therapeutics has raised $362.74M.
Akamis Bio and iTeos Therapeutics operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Akamis Bio with someone else

Start typing a company name or domain.

Related Comparisons

Compiled from the BounceWatch company index. We last looked at Akamis Bio on 12 Sep 2024, and iTeos Therapeutics on 11 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes